This chapter provides an overview of the general principles that should guide antimicrobial stewardship programs (ASPs) in every hospital setting. Principles and strategies related to optimal antibiotic therapy, major problems encountered in ASPs (i.e., antibiotic resistance, Clostridium difficile...

This chapter introduces the report, which describes the animal and human health costs and benefits impact of pets in the UK.

This chapter discusses the methodology used to obtain data on the economic significance of companion animals in the UK.

This chapter describes the extent and economic significance of the pet-keeping phenomenon, benefits of pet ownership and associated problems of pet ownership in the UK based on the Council for Science and Society (CSS) report 1988.

The current status of the companion animal-keeping phenomenon and subsequent pet care industry in the UK is described, with emphasis on some of the possible benefits and costs to certain economies that are associated with companion animals.

This chapter describes two areas that show the significance of indirect costs associated with companion animals: (i) the effect of companion animal ownership on human health (considering examples relating to the physical, mental and social health of people) and its economic implications and (ii)...

The need for further research and follow up studies on the economic impact of companion animals on the UK economy is briefly discussed.

Creating an institutional IV to PO conversion policy is an easy way for antimicrobial stewardship programmes to demonstrate value while improving patient outcomes, reducing resistance, reducing cost, and improving patient safety. This chapter will further discuss the reasons behind IV to PO...

This chapter reviews the components of an antimicrobial stewardship programme (ASP) that are required for the successful reduction of antimicrobial expenditures, especially through formulary management and the optimization of patient therapy and outcomes, with the final goal of reducing the burden...

This chapter gives an overview about: the cost of pathogen resistance and the role of antimicrobial stewardship programmes (ASPs); economic measures of ASP performance; ASPs usually lack a state-of-the-art economic analysis; ASPs in the era of limited resources; and the future of ASPs.